MedPath

The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital Rejuvenatio

Phase 4
Recruiting
Conditions
Healthy Patient
Bipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital Rejuvenation
Registration Number
TCTR20230417001
Lead Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
38
Inclusion Criteria

1. Aged 30-65 years
2. Both male and Female
3.Tear trough with mild to moderate skin laxity at eye

Exclusion Criteria

1. Subjects who are pregnant or lactation
2. Subjects who had history of low platelet, coagulopathy, anemia, liver disease, cancer, immunocompromised host or epilepsy
3. Subjects who has dermatits, wound or infection at treatment area
4. Subjects who allergy to anesthesia cream
5. Subjects who taken oral or injection contraceptive pills or coagulopathy drug
6. Subjects who had history of botulinum toxin treatment within 12 months before arrived the project
7. Subjects who had history of laser at treatment area within 6 months before arrived the project 8. Subjects who had history of keloid or hypertrophic scar
9. Subjects who had history of psychitic disease
10. Subjects who had metalic equipment in the body

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Volume change Baseline, 1 month,3 months, 6 months Vectra
Secondary Outcome Measures
NameTimeMethod
Skin Texture and Wrinkle Baseline, 1 month,3 months, 6 months Antera,Skin elasticity Baseline, 1 month,3 months, 6 months Cutometer,Doctor Evaluation Baseline, 1 month,3 months, 6 months Quatile Scale,Patient Evaluation Baseline, 1 month,3 months, 6 months Quatile scale,Pain Score Baseline Visual Analog Scale,safety Baseline, 1 month,3 months, 6 months Adverse Effect
© Copyright 2025. All Rights Reserved by MedPath